miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway.
miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway.
复制标题
靶向 RXR α 的 miR-27a-3p 通过激活 Wnt/β-catenin 通路促进结直肠癌进展
DOI:
10.18632/oncotarget.19635
复制
发表时间:
2017-10-10
期刊:
影响因子:
--
通讯作者:
Han A
中科院分区:
文献类型:
--
作者:
Liang J;Tang J;Shi H;Li H;Zhen T;Duan J;Kang L;Zhang F;Dong Y;Han A
This study aimed to elucidate how miR-27a-3p modulates the Wnt/β-catenin signaling pathway to promote colorectal cancer (CRC) progression. Our results showed that the expression of miR-27a-3p was up-regulated in CRC and closely associated with histological differentiation, clinical stage, distant metastasis and CRC patients’ survival. miR-27a-3p mimic suppressed apoptosis and promoted proliferation, migration, invasion of CRC cells in vitro and in vivo. Whereas miR-27a-3p inhibitor promoted apoptosis and suppressed proliferation, migration, invasion of CRC cells in vitro and in vivo. Furthermore, RXRα was the target gene of miR-27a-3p in CRC. miR-27a-3p expression negatively correlated with RXRα expression in CRC tissues. The underlining mechanism study showed that miR-27a-3p/RXRα/Wnt/β-catenin signaling pathway is involved in CRC progression. In conclusion, our findings first demonstrate that miR-27a-3p is a prognostic and/or potential therapeutic biomarker for CRC patients and RXRα as miR-27a-3p targeting gene plays an important role in activation of the Wnt/β-catenin pathway during CRC progression.